logo
Select company
Select metric
$ -7.43EBITDA per Share
VS
Market
3
Sector
8
Industry
10
History
94
$ 2.12Close
$ 1.86 - $ 7.1 52-Week Range
Ticker Information

Ticker

INM

Company Name

INMED PHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

INMED PHARMACEUTICALS INC - EBITDA per Share Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

INM - EBITDAPS Historical data
DateEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)EBITDA per ShareShare FactorWeighted Average Shares
6/30/2025$ -7.26M$ -7.431975.99K
3/31/2025$ -7.4M$ -6.7511.1M
12/31/2024$ -6.98M$ -9.881706.55K
9/30/2024$ -6.21M$ -10.011620.13K
6/30/2024$ -7.06M$ -18.541381.05K
3/31/2024$ -5.47M$ -11.381480.65K
12/31/2023$ -5.75M$ -14.411398.67K
9/30/2023$ -6.37M$ -38.291166.41K
6/30/2023$ -7.34M$ -59.941122.42K
3/31/2023$ -14.87M$ -89.351166.41K
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • INMED PHARMACEUTICALS INC's latest trailing twelve months (TTM) EBITDAPS stands at $ 0.
  • Over the past 5 years, INMED PHARMACEUTICALS INC's average EBITDAPS has been $ -212.51.
  • The median EBITDAPS for INMED PHARMACEUTICALS INC during this period was $ -59.94
  • INMED PHARMACEUTICALS INC reached its highest EBITDAPS over the past 5 years at $ -6.75.
  • The lowest EBITDAPS recorded by INMED PHARMACEUTICALS INC in the same timeframe $ -715.33

INMED PHARMACEUTICALS INC's EBITDAPS vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDAPS Benchmarks
CompanyEBITDAPS
NBY : NOVABAY PHARMACEUTICALS INC $ 0.62XBIO : XENETIC BIOSCIENCES INC $ -2SPRB : SPRUCE BIOSCIENCES INC $ -77.5CPHI : CHINA PHARMA HOLDINGS INC $ -0.53ONCO : ONCONETIX INC $ -77.07SXTP : 60 DEGREES PHARMACEUTICALS INC $ -5.26BNBX : APPLIED DNA SCIENCES INC $ -22.47ADTX : ADITXT INC $ -14.17CDT : CONDUIT PHARMACEUTICALS INC $ -14.97GTBP : GT BIOPHARMA INC $ -3.39

Similar metrics to Shares WA:

Definition of EBITDA per Share

[Calculation] The amount of earnings before interest, taxes, depreciation, and amortization attributed to each share, calculated as [EBITDA] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
EBITDA / (Shares WA * Share Factor)
(=) EBITDAPS EBITDAPS for INMED PHARMACEUTICALS INC is calculated as follows: EBITDA [ $ 0 ] / (Shares WA [ 10.44K ] * Share Factor [ 1 ])
(=) EBITDAPS [ $ 0 ]

INM - EBITDA per Share, Last 5 years

$ -715.33

Minimum

Jun 30, 2021

$ -6.75

Maximum

Mar 31, 2025

$ -212.51

Average

$ -59.94

Median

EBITDAPS Benchmark Analysis

 The chart above depicts the distribution of EBITDAPS for companies in the Total Stock Market. The average EBITDAPS of the companies is $ 2.03 with a standard deviation of $ 4.28.
The following table provides additional summary stats:
EBITDAPS in the Market:
filtered constituents3.78K
min$ -11.29
max$ 14.03
average$ 2.03
median$ 1
std$ 4.28